Skip To Main Content
Yinghao Lu on Muck Rack

Yinghao Lu

As seen in: Nature, MDPI, BMC Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinghao

Contact Yinghao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Predicting radiation esophagitis after lung cancer radiotherapy using dose-volume, radiomic and dosiomic features: an external validation study

|
By Libin Liu, Shaofeng Wang, Xiqing Li, Nuo Zheng, Xiaolong Lin, Tingxiong Xiao, Yinghao Lu, Qin Shi, Tingying Chen, Yuyin Le
| Nature Verified
Abstract Acute radiation esophagitis can interrupt thoracic radiotherapy, but it remains unclear whether image- and dose-derived features improve prediction beyond dose-volume histogram (DVH) metrics and retain their performance across institutions. We externally validated seven models based on different combinations of clinical, DVH, radiomic and dosiomic predictors for Grade ≥ 2 acute radiation esophagitis using 226 Fuzhou patients for development and 76 Xiamen patients for external validation.
Open in Who Shared Issue with article?

Computer Science > Computer Vision and Pattern Recognition

|
By Yinghao Lu, Zhehao Li, Chenchen Yan
| arXiv
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (341) Issue with article?

Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma - BMC Cancer

|
By Yinghao Lu, Limin Liao, Kunpeng Du, Jianhua Mo, Xia Zou, Jiahui Chen, Wenwen Tang, Liwei Su, Jieping Wu, Yujing Tan, Junxian Liang, Junde Zhang
| BMC Cancer Verified
References Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med (2005), 987–996. https://doi.org/10.1056/NEJMoa043330.
Open in Who Shared Issue with article?
See all 4 articles